GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Human Health Holdings Ltd (HKSE:01419) » Definitions » Cash Flow from Financing

Human Health Holdings (HKSE:01419) Cash Flow from Financing : HK$-125.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Human Health Holdings Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Human Health Holdings paid HK$0.0 Mil more to buy back shares than it received from issuing new shares. It spent HK$3.2 Mil paying down its debt. It paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent HK$60.6 Mil paying cash dividends to shareholders. It spent HK$4.0 Mil on other financial activities. In all, Human Health Holdings spent HK$67.9 Mil on financial activities for the six months ended in Dec. 2023.


Human Health Holdings Cash Flow from Financing Historical Data

The historical data trend for Human Health Holdings's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Health Holdings Cash Flow from Financing Chart

Human Health Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.50 -64.75 -59.30 -67.45 -178.29

Human Health Holdings Semi-Annual Data
Jun13 Jun14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.92 -31.53 -146.23 -32.05 -93.46

Human Health Holdings Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Human Health Holdings's Cash from Financing for the fiscal year that ended in Jun. 2023 is calculated as:

Human Health Holdings's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-125.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Human Health Holdings  (HKSE:01419) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Human Health Holdings's issuance of stock for the six months ended in Dec. 2023 was HK$0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Human Health Holdings's repurchase of stock for the six months ended in Dec. 2023 was HK$0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Human Health Holdings's net issuance of debt for the six months ended in Dec. 2023 was HK$-3.2 Mil. Human Health Holdings spent HK$3.2 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Human Health Holdings's net issuance of preferred for the six months ended in Dec. 2023 was HK$0.0 Mil. Human Health Holdings paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Human Health Holdings's cash flow for dividends for the six months ended in Dec. 2023 was HK$-60.6 Mil. Human Health Holdings spent HK$60.6 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Human Health Holdings's other financing for the six months ended in Dec. 2023 was HK$-4.0 Mil. Human Health Holdings spent HK$4.0 Mil on other financial activities.


Human Health Holdings Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Human Health Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Health Holdings (HKSE:01419) Business Description

Traded in Other Exchanges
N/A
Address
12th Floor, 3 Sheung Yuet Road, Phase 2, Enterprise Square Two, Kowloon Bay, Kowloon, Hong Kong, HKG
Human Health Holdings Ltd is engaged in the provision of healthcare services. The company segments include general practice services, specialties services, and dental services. It offers general practice services, including general consultation, diagnostics, and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Cardiology, Dental Implant, Urology, work injury assessment services, Orthodontics and others. The company generates maximum revenue from the general practice services segment.
Executives
Bei Jing Feng Huang Lian He Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Xu Jie 2201 Interest of corporation controlled by you
Treasure Group Global Limited 2101 Beneficial owner
Capital Healthcare International Limited 2101 Beneficial owner
Chan Kin Ping 2201 Interest of corporation controlled by you
Pang Lai Sheung 2201 Interest of corporation controlled by you
Shou Du Yi Liao Jian Kang Chan Ye Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you

Human Health Holdings (HKSE:01419) Headlines

No Headlines